Cancer News and Research

Latest Cancer News and Research

Affymax and Takeda announce agreement for commercialization of Hematide for anemia

Affymax and Takeda Pharmaceutical Company have announced that the companies have entered into an exclusive global agreement to develop and commercialize Affymax's lead product candidate, Hematide, for the treatment of anemia.

27 Jun 2006

Shift in prostate cancer Gleason grades from 1989 to 2001

Since the clinical introduction of PSA testing, there is reason to hypothesize that prostate cancer (CaP) Gleason grades may have shifted due to a variety of factors.

26 Jun 2006

Stem cells contain immortal DNA

EuroStemCell scientists at the Pasteur Institute in Paris have demonstrated one of the body's most sophisticated ways of regulating the genetic material of stem cells.

26 Jun 2006

Stroke damage may be reversible

Scientists in the U.S. say they have discovered a way to make the brain reverse the damage it suffers after a stroke, and are optimistic that it will lead to treatment which will exploit the body's ability to heal itself.

26 Jun 2006

Injection may prevent infertility in men receiving cancer chemotherapy

It may be possible to protect the testes of cancer patients against the loss of fertility caused by chemotherapy.

20 Jun 2006

Blacks have poorer survival rate for skin cancer

Researchers have found that among patients suffering from melanomas, those from a black or Hispanic background were more likely than whites to have the advanced stage of melanoma at the time of diagnosis.

20 Jun 2006

New push to tackle priorities in sexual and reproductive health

Leaders of the World Health Organization (WHO) and UNFPA, the United Nations Population Fund, are coordinating action to reverse the global trend of deteriorating levels of sexual and reproductive health and reduce the adverse impact on mothers, babies and young people.

20 Jun 2006

Two year wait for breast cancer test results drives women to consider radical surgery

Women in the UK being put under added stress because they are experiencing delays of two years or more for test results to see if they carry a gene associated with an increased likelihood of breast cancer.

20 Jun 2006

New genetic clue discovered about breast cancer

New research has discovered that women in Iceland with a particular gene that raises the risk of breast cancer were virtually certain to develop the disease if they also had a mutation in another gene.

20 Jun 2006

Too much night light raises breast cancer risk

According to American researchers women who are exposed to too much light at night could suffer a disruption of crucial hormones and raise their risk of developing breast tumours.

20 Jun 2006

New highly successful method of freezing human eggs

A new and highly successful method of freezing human eggs will help to even out the current inequality between men and women.

19 Jun 2006

New test spares couples with familial cancer the trauma of termination

A new way of sparing couples the trauma of having to decide between having a baby with a high risk of developing a form of colorectal cancer later in life, or terminating the pregnancy, will be revealed on Tuesday, 20 June 2006.

19 Jun 2006

Common genetic prostate cancer variant identified

Prostate cancer (CaP) is a presumed result of both genetic and environmental events.

19 Jun 2006

From DNA to RNA to protein

Of the thousands of proteins produced in our cells, few are as important as the enzyme RNA polymerase (RNAP), which has the unique ability to faithfully copy genetic information from DNA.

18 Jun 2006

Researchers identify new keys to regulation of bacterial gene expression

The cellular process of transcription, in which the enzyme RNA polymerase constructs chains of RNA from information contained in DNA, depends upon previously underappreciated sections of both the DNA promoter region and RNA polymerase

18 Jun 2006

First drug treatment for late-stage cervical cancer approved

FDA has approved a combination of Hycamtin (topotecan hydrochloride) and cisplatin for use as the first drug treatment for women with late-stage cancer of the cervix.

18 Jun 2006

New leukemia drug gives renewed hope to those battling drug resistance to the disease

New research offers hope for victims of chronic myeloid leukemia (CML) battling drug resistance to the disease.

18 Jun 2006

Low-dose exposure to arsenic in drinking water increases risk for skin lesions

Mailman School of Public Health study provides evidence that a population exposed to well water with arsenic concentrations of as little as 50 ug/l is at risk for skin lesions.

14 Jun 2006

Burkitt lymphoma gene expression signature identified

An international research study involving the University of Nebraska Medical Center, the National Cancer Institute and 10 other institutions has successfully identified the gene expression signature for Burkitt lymphoma.

14 Jun 2006

Dasatinib offers new options for leukemia patients

Dasatinib, an experimental drug under development by Bristol-Myers Squibb, reverses the signs and symptoms of patients whose chronic myeloid leukemia has failed to respond to Gleevec, which is considered the standard of treatment for the disorder.

14 Jun 2006